CHEBI:28908 - bambermycin

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name bambermycin
ChEBI ID CHEBI:28908
Definition A glycophospholipid antibiotic compound with the lipid portion conjugated to a pentasaccharide fraction via a phosphate linkage.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:5075, CHEBI:25360
Supplier Information
Download Molfile XML SDF
Formula C69H107N4O35P
Net Charge 0
Average Mass 1583.56740
Monoisotopic Mass 1582.64535
InChI InChI=1S/C69H107N4O35P/c1-30(2)15-14-17-31(3)18-19-33(5)22-25-68(9,10)24-13-12-16-32(4)23-26-96-41(60(88)89)29-98-109(94,95)108-66-56(57(107-67(70)92)69(11,93)58(106-66)61(90)91)105-63-44(72-36(8)76)47(81)54(40(101-63)28-97-64-51(85)48(82)45(79)39(27-74)100-64)103-62-43(71-35(7)75)46(80)53(34(6)99-62)102-65-52(86)49(83)50(84)55(104-65)59(87)73-42-37(77)20-21-38(42)78/h13,15,18,23-24,34,39-41,43-58,62-66,74,77,79-86,93H,5,12,14,16-17,19-22,25-29H2,1-4,6-11H3,(H2,70,92)(H,71,75)(H,72,76)(H,73,87)(H,88,89)(H,90,91)(H,94,95)/b24-13+,31-18+,32-23+/t34-,39-,40-,41-,43-,44-,45-,46-,47-,48+,49+,50-,51-,52-,53-,54-,55+,56-,57-,58-,62+,63+,64-,65-,66-,69+/m1/s1
InChIKey PERZMHJGZKHNGU-JGYWJTCASA-N
SMILES C[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](NC(C)=O)[C@@H](O[C@@H]2CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)O[C@H]2[C@H](O[C@H](C(O)=O)[C@@](C)(O)[C@@H]2OC(N)=O)OP(O)(=O)OC[C@@H](OC\C=C(/C)CC\C=C\C(C)(C)CCC(=C)C\C=C(/C)CCC=C(C)C)C(O)=O)[C@H](NC(C)=O)[C@@H](O)[C@@H]1O[C@@H]1O[C@@H]([C@H](O)[C@H](O)[C@H]1O)C(=O)NC1=C(O)CCC1=O
Roles Classification
Biological Role(s): antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing bambermycin (CHEBI:28908) has role antimicrobial agent (CHEBI:33281)
bambermycin (CHEBI:28908) is a glycophospholipid (CHEBI:24397)
IUPAC Name
(2S,3S,4R,5R,6R)-5-{[(2S,3R,4R,5S,6R)-3-acetamido-5-{[(2S,3R,4R,5S,6R)-3-acetamido-4-hydroxy-6-methyl-5-({(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)carbamoyl]tetrahydro-2H-pyran-2-yl}oxy)tetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}methyl)tetrahydro-2H-pyran-2-yl]oxy}-4-(carbamoyloxy)-6-({[(2R)-2-carboxy-2-{[(2E,6E,13E)-3,8,8,14,18-pentamethyl-11-methylenenonadeca-2,6,13,17-tetraen-1-yl]oxy}ethoxy](hydroxy)phosphoryl}oxy)-3-hydroxy-3-methyltetrahydro-2H-pyran-2-carboxylic acid
INNs Sources
Bambermicina ChemIDplus
Bambermycine ChemIDplus
Bambermycinum ChEBI
Synonyms Sources
Bambermycin KEGG COMPOUND
Bambermycins ChemIDplus
Bambermycins [USAN] ChemIDplus
Flavomycin KEGG COMPOUND
Flavophospholipol ChemIDplus
Moenomycin ChemIDplus
Moenomycin A KEGG COMPOUND
Moenomycin a ChemIDplus
Manual Xrefs Databases
C06765 KEGG COMPOUND
D03050 KEGG DRUG
US3674866 Patent
View more database links
Registry Numbers Types Sources
11015-37-5 CAS Registry Number KEGG COMPOUND
11015-37-5 CAS Registry Number ChemIDplus
3548899 Beilstein Registry Number Beilstein
5237474 Beilstein Registry Number Beilstein
Last Modified
19 August 2009